Cardiovascular risk profile in nondiabetic renal transplant patients: Cyclosporine versus tacrolimus

Transplantation Proceedings

Volumn 35, Issue 5, 2003, Pages 1727-1729

  Hernández, Domingo ^a   Alvarez, A ^a   Torres, A ^a   Oppenheimer, F ^a   Cobo, M ^a   Gonzalez Posada J ^a   Jimenez A ^a   Lorenzo, V ^a   Torregrosa, V ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DYSLIPIDEMIA; GRAFT REJECTION; HUMAN; HYPERLIPIDEMIA; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; OBESITY; PATIENT CARE; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; SURVIVAL RATE;

EID: 0041330669     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00630-4     Document Type: Conference Paper

References (10)

1. Kendrick E. Am J Kidney Dis. 38:(suppl 6):2001;S36.
2. Henry M.L. Clin Transplantation. 13:1999;209.
3. Mayer A.D., Dmitrewski J., Squifflet J.P., et al. Transplantation. 64:1997;436.
4. Margreiter R. Lancet. 359:2002;741.
5. Vincenti F., Jensik S.C., Filo R.S., et al. Transplantation. 73:2002;775.
6. Boots J.M.M., van Duijnhoven E.M., Christiaans M.H.L., et al. Transpl Int. 14:2001;370.
7. van Duijnhoven E.M., Christiaans M.H.L., Boots J.M.M., et al. J Am Soc Nephrol. 13:2002;213.
8. Moore R., Hernandez D., Valantine H. Drug Saf. 24:2001;755.
9. Maes B.D., Kuypers D., Messiaen T., et al. Transplantation. 72:2001;1655.
10. Ligtenberg G., Hené R.J., Blankestijn P.J., et al. J Am Soc Nephrol. 12:2001;368.